Aptus Pharma Ltd vs Lactose India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Aptus Pharma Ltd is ₹ 413 as of 04 May 10:02 . The P/E Ratio of Aptus Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Lactose (India) Ltd changed from 30.7 on March 2022 to 21.6 on March 2025 . This represents a CAGR of -8.41% over 4 years The Market Cap of Aptus Pharma Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Lactose (India) Ltd changed from ₹ 30.54 crore on March 2021 to ₹ 111.66 crore on March 2025 . This represents a CAGR of 29.60% over 5 years The revenue of Aptus Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Lactose (India) Ltd for the Dec '25 is ₹ 37.4 crore as compare to the Sep '25 revenue of ₹ 41.55 crore. This represent the decline of -9.99% The ebitda of Aptus Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Lactose (India) Ltd for the Dec '25 is ₹ 3.7 crore as compare to the Sep '25 ebitda of ₹ 5.63 crore. This represent the decline of -34.28% The net profit of Aptus Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Lactose (India) Ltd changed from ₹ 2.27 crore to ₹ 0.53 crore over 7 quarters. This represents a CAGR of -56.45% The Dividend Payout of Aptus Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Lactose (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aptus Pharma Ltd

Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010.
Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre. Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements.
It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products.

About Lactose (India) Ltd

Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat.
The company is engaged in the manufacturing and trading of pharmaceutical products.
They offer edible and pharmaceutical grade lactose, which is used as an ingredient in pharmaceutical products, as well as in the dairy, food, confectionery, and beverage industries.
The company also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee.
Further, they engage in the contract manufacture of pharmaceutical products. The company is having their manufacturing facilities located at Vadodara in Gujarat.

FAQs for the comparison of Aptus Pharma Ltd and Lactose (India) Ltd

Which company has a larger market capitalization, Aptus Pharma Ltd or Lactose (India) Ltd?

Market cap of Aptus Pharma Ltd is 277 Cr while Market cap of Lactose (India) Ltd is 142 Cr

What are the key factors driving the stock performance of Aptus Pharma Ltd and Lactose (India) Ltd?

The stock performance of Aptus Pharma Ltd and Lactose (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aptus Pharma Ltd and Lactose (India) Ltd?

As of May 4, 2026, the Aptus Pharma Ltd stock price is INR ₹405.0. On the other hand, Lactose (India) Ltd stock price is INR ₹113.07.

How do dividend payouts of Aptus Pharma Ltd and Lactose (India) Ltd compare?

To compare the dividend payouts of Aptus Pharma Ltd and Lactose (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.